Black Knight selling unit to win clearance for acquisition by IntercontinentalExchange

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

United States News News

United States United States Latest News,United States United States Headlines

Black Knight Inc. and Intercontinental Exchange Inc. cut the value of their merger deal by about $1.4 billion on Tuesday after Black Knight said it’s selling...

Black Knight Inc. BKI and Intercontinental Exchange Inc. ICE cut the value of their merger deal by about $1.4 billion on Tuesday after Black Knight said it’s selling its Empower loan origination system to Constellation Software Inc. CA:CSU to win clearance for its deal with ICE with U.S. regulators. Black Knight did not provide a purchase price for its Empower loan origination system, which includes Exchange, LendingSpace and Aiva solutions.

4 billion on Tuesday after Black Knight said it’s selling its Empower loan origination system to Constellation Software Inc. CSU to win clearance for its deal with ICE with U.S. regulators. Black Knight did not provide a purchase price for its Empower loan origination system, which includes Exchange, LendingSpace and Aiva solutions. The companies said the deal is partly to secure clearance of ICE’s proposed acquisition of Black Knight under the Hart-Scott Rodino Act.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in US

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

BioMarin’s stock falls after another company’s dwarfism drug moves into Phase 3 clinical trialsShares of BioMarin Pharmaceutical Inc. were down about 6.0% in premarket trading on Monday after BridgeBio Pharma Inc. shared positive Phase 2 clinical data...
Source: MarketWatch - 🏆 3. / 97 Read more »